Cite
HARVARD Citation
Greenberg, B. et al. (2022). A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse. Multiple sclerosis journal, experimental, translational and clinical. 8 (2), p. . [Online].